Klinar CRO   Report issue

For profit Phase 2
Founded: Ankara Turkey (2009)

Organization Overview

First Clinical Trial
2017
NCT03058224
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Klinar CRO

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4